Specifically, the overexpression of BET proteins has been observed in several types of tumors, such as acute myelogenous leukemia (AML), Burkitt lymphoma (BL), multiple myeloma (MM), prostate cancer (PCa), and breast cancer [271,272]. This evidence concerns the gene DNER and acute myeloid leukemia.